The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical feasibility of circulating tumor DNA alterations in patients with advanced hepatocellular carcinoma.
 
Gwangil Kim
No Relationships to Disclose
 
Sohyun Hwang
No Relationships to Disclose
 
Haeyoun Kang
No Relationships to Disclose
 
Jaekyung Cheon
Consulting or Advisory Role - Eisai; Roche
Research Funding - Bayer
 
Beodeul Kang
No Relationships to Disclose
 
Chan Kim
Honoraria - BMS; MSD; Ono Pharmaceutical; Roche
Consulting or Advisory Role - BMS; MSD; Oncocross; ONEGENE BIOTECHNOLOGY; Ono Pharmaceutical; Panolos Bioscience
Research Funding - Boryung; CHA vaccine institute; Dong-A ST; Oncocross; Roche (Inst); Samyang; Virocure
 
Hong Jae Chon
Consulting or Advisory Role - AstraZeneca; Bayer; BMS; Celgene Cancer Care Links/BMS; Eisai; Green Cross; Menarini; MSD Oncology; Ono Pharmaceutical; Roche; Sanofi; SERVIER; Sillajen
Speakers' Bureau - Bayer; BMS; Celgene/Bristol-Myers Squibb; Dong-A ST; Eisai; Menarini; Roche; Sanofi; SERVIER
Research Funding - Boryung (Inst); Dong-A ST (Inst); Roche (Inst)